Phibro Animal Health | PAHC - 股票

金融业

USD

USD 1.45B

现金及等价物

USD 54.93M

USD 240.42M

USD 894.07M

USD 281.87M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 361.83M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 597.69M

USD 1.46B

USD 27.46M

USD 361.83M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 539.7M

贸易债权人

USD 129.64M

应收帐款人

USD 215.87M

	股票	更改		日
Align Technology	USD 212.24M		2.7M	2026-06
ANI Pharmaceuticals	USD 143.47M		401K	2026-03
Aurora Cannabis	CAD 175.08M		55.48M	2026-03
Bristol-Myers Squibb	USD 2.74B		19M	2026-06
Canopy Growth	CAD 110.51M		4.96M	2026-03
Corcept Therapeutics	USD 13.18M		295K	2026-06
Eli Lilly	USD 16.79B		2.26B	2026-06
Henry Schein	USD 2.06B		45M	2026-06
Idexx Laboratories	USD 391.58M		9.18M	2026-06
Knight Therapeutics	CAD 95.4M		2.91M	2024-03
Merck	USD 6.48B		179M	2026-03
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Pacira	USD 134.57M		15.8M	2026-06
Phibro Animal Health	USD 539.7M		22.35M	2026-03
Prestige Brands	USD 190.22M		31.08M	2026-06
Supernus Pharmaceuticals	USD 107.03M		3.74M	2026-06
Zoetis	USD 2.57B		24M	2026-06